Category: 2016, No. 11

A 5-year prospective study of type 2 diabetes patients in Shanghai Xinjing Community 3.The regression and promoting factors of diabetic retinopathy and diabetic macular edema in Chinese type 2 diabetes patients

Authors:Jin Peiyao,  Peng Jinjuan,  Zou Haidong,  Xu Xun,  Zhang Xi,  Wang Weiwei,  Fu Jiong,  Bai Xuelin DOI: 10.3760/cma.j.issn.2095-0160.2016.11.014 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1025-1030. Abstract Background Long-term study on type 2 diabetes discovered that some patients with diabetic retinopathy (DR) or diabetic macular edema (DME) appear regression of lesions without invasive ocular intervention but only systemic medication.These mechanisms remain unclear. Objective […]

The era of minimally invasive glaucoma surgery

Authors:Zhou Jichao,  Zhang Chun DOI: 10.3760/cma.j.issn.2095-0160.2016.11.020 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1052-1056. Abstract The chance of glaumatic optic nerve injury increases with the intraocular pressure.Reducing the intraocular pressure has an important significance for slowing the process of glaucoma.Surgery is one of the most important means to lower the intraocular pressure.With the classic operation of the […]

Current research of hyaluronic acid and thyroid-associated ophthalmopathy

Authors:Chen Xiaoling,  He Weimin DOI: 10.3760/cma.j.issn.2095-0160.2016.11.018 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1047-1050. Abstract Thyroid-associated ophthalmopathy (TAO) is a common orbital disease in the adults, and glycosaminoglycan deposits in the periorbital connective tissue is one of important pathological features.Hyaluronic acid is the main component of glycosaminoglycan, which is extremely hydrophilic and viscoelastic, so that it is […]

A review of the association between nuclear receptors and ocular diseases

Authors:Liu Ke,  Qin Bo,  Zou Chang DOI: 10.3760/cma.j.issn.2095-0160.2016.11.017 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1042-1046. Abstract Nuclear receptor is one of abundant transcription factors in human body.Interacted with corresponding ligands, coactivators and corepressors, nuclear receptor can regulate the expression of genes and plays important roles in the development, cell differentiation, physiological and metabolic processes.Many diseases are directly […]

Pediatric refractive surgery

Authors:Jiang Jingjing,  Wu Qian DOI: 10.3760/cma.j.issn.2095-0160.2016.11.016 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1038-1041. Abstract Refractive error is an important cause of amblyopia.The traditional treatments of amblyopia in children are wearing glasses and occlusion.Children who suffered from some specific diseases, such as severe anisometropia, neurobehavioral disorders and facial dysplasia, can not tolerate traditional treatments.In recent years, refractive […]

A systematic review of the efficiency and safety of intra-arterial chemotherapy for retinoblastoma

Authors:Gao Jingge,  Chen Danian DOI: 10.3760/cma.j.issn.2095-0160.2016.11.015 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1031-1037. Abstract Background Retinoblastoma (RB) is the most common primary ocular malignancy in children.Many treatment modalities have been applied to RB.As an exciting option to reduce systemic adverse effects and increase the local drug concentration, intra-arterial chemotherapy (IAC) was introduced as an important treatment […]

A meta-analysis of selective laser trabeculoplasty versus antiglaucomatous medication for glaucomatous and ocular hypertensive eyes

Authors:Wei Yahui,  Li Xueying,  Cai Yu DOI: 10.3760/cma.j.issn.2095-0160.2016.11.013 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1019-1024. Abstract Background Selective laser trabeculoplasty (SLT) and antiglaucomatous medications can be used to treat both glaucoma and ocular hypertension.However, which is more effective and safe remains proofless. Objective This meta-analysis was to identify the possible differences in clinical outcomes between SLT and […]

Morphological and functional changes of ocular surface and meibomian glands in perimenopausal syndrome in meibomian gland dysfunction

Authors:Yang Liu,  Hou Haiyan,  Meng Zhu,  Zhao Jinrong,  Zhao Shaozhen DOI: 10.3760/cma.j.issn.2095-0160.2016.11.012 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1014-1018. Abstract Background Perimenopausal syndrome (PMS) which changes in physiology, pathology and hormone levels, brings a series of ocular and systemic health problems, such as dry eye, meibomian gland dysfunction (MGD), obesity, coronary heart disease and osteoporosis etc. Objective This study […]

Comparison of therapeutic effects between a new warm moist air device assisted with eyelid massage and eyedrops with only eyedrops for meibomian gland dysfunction

Authors:Zhao Bing,  Zhang Xiaolin,  Sun Liqun,  Zhang Xiaobo DOI: 10.3760/cma.j.issn.2095-0160.2016.11.011 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1009-1013. Abstract Background Meibomian gland dysfunction (MGD) is a common eye disease that leads to ocular surface damage.Conventional treating method is hot compress with heating pads or warm towels combined with eyelid massage, but the temprature of heat source is difficult to […]

Clinical characteristics of corneal endotheliitis and endothelial rejection following corneal transplantation

Authors:Sun Xiaonan,  Xiao Gege,  Feng Yun,  Pei Yong,  Hong Jing DOI: 10.3760/cma.j.issn.2095-0160.2016.11.009 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1002-1007. Abstract Background The administration of glucocorticoid drugs and immunosupressor results in reducing immune competence and therefore induces inflammatory lesions, such as corneal endotheliitis and endothelial rejection.Corneal endotheliitis and endothelial rejection have rather similar clinical manifestations, but their managements are different, […]